FDA
-
-
-
-
-
-
-
Nutriband CEO issues year-end letter highlighting 2025 achievements
-
-
-
-
-
-
-
Nutriband partners with Brand Institute for fentanyl patch naming
-
-
-
-
-
-
-
Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval
-
-
-
-
-
-
-
Nutriband (NTRB) Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
-
-
-
-
-
-
-
Nutriband Issues Letter to Shareholders
-
-
-
-
-
-
-
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17
-
-
-
-
-
-
-
Nutriband Inc. Authorizes $1M Share Buyback Program
-
331,676 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

